相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis B reactivation and immune check point inhibitors
Benoit Godbert et al.
DIGESTIVE AND LIVER DISEASE (2021)
Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma
Colm J. O'Rourke et al.
HEPATOLOGY (2020)
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma?
Deborah Malvi et al.
HISTOPATHOLOGY (2020)
Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis
Xiaoli Sun et al.
CELL METABOLISM (2020)
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
Peter G. Hendrickson et al.
ONCOIMMUNOLOGY (2020)
Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
Sylvie Job et al.
HEPATOLOGY (2020)
The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis
Maki Tobari et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
Miryam Müller et al.
JOURNAL OF HEPATOLOGY (2020)
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T. Flaherty et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development
Simona-Rebeca Ignat et al.
CELLS (2020)
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
Donghua Shi et al.
CLINICAL CANCER RESEARCH (2020)
Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma
Daisuke Uchida et al.
NUTRIENTS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Expression of TLR-2 in hepatocellular carcinoma is associated with tumour proliferation, angiogenesis and Caspase-3 expression
Fatma El-Zahraa Ammar Mohamed et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
Michele Dal Bo et al.
DRUG RESISTANCE UPDATES (2020)
Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies
Qi Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos
G. Brandi et al.
CANCER GENETICS (2020)
Characteristics of genomic alterations in Chinese cholangiocarcinoma patients
Guoping Jiang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
Bo-Hao Zheng et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
The intestinal microbiota fuelling metabolic inflammation
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy
Anthony Tanoto Tan et al.
GASTROENTEROLOGY (2019)
Obesity: global epidemiology and pathogenesis
Matthias Blueher
NATURE REVIEWS ENDOCRINOLOGY (2019)
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Ruidong Xue et al.
CANCER CELL (2019)
Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease
Min Zhu et al.
CELL (2019)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
NATURE MEDICINE (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The Role of DNA Repair Glycosylase OGG1 in Intrahepatic Cholangiocarcinoma
Kazuhito Sakata et al.
ANTICANCER RESEARCH (2019)
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
Robert L. Ferris et al.
CLINICAL CANCER RESEARCH (2019)
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
Agrin Moeini et al.
GASTROENTEROLOGY (2019)
Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications
Elisabetta Cariani et al.
LIVER INTERNATIONAL (2019)
Immunotherapy for hepatocellular carcinoma: Current and future
Michael P. Johnston et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
Amit Mahipal et al.
CANCERS (2019)
Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life
Daneng Li et al.
CANCERS (2019)
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Xiaofan Ding et al.
GASTROENTEROLOGY (2019)
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
Chen Lu et al.
MOLECULAR CANCER (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells
Bin Sun et al.
CANCER IMMUNOLOGY RESEARCH (2019)
LBA3IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)
A-L Cheng et al.
ANNALS OF ONCOLOGY (2019)
Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
Shehua Qian et al.
EPMA JOURNAL (2019)
Immune checkpoint inhibitors win the 2018 Nobel Prize
Pei-Wei Huang et al.
BIOMEDICAL JOURNAL (2019)
Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma
Jian-Min Yuan et al.
CARCINOGENESIS (2019)
Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma
Benjamin Goeppert et al.
HEPATOLOGY (2019)
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Jesus M. Banales et al.
HEPATOLOGY (2019)
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
Xiufeng Liu et al.
ONCOLOGIST (2019)
Immunobiology of cholangiocarcinoma
Emilien Loeuillard et al.
JHEP REPORTS (2019)
Liver Macrophages: Old Dogmas and New Insights
Adrien Guillot et al.
HEPATOLOGY COMMUNICATIONS (2019)
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Hiroshi Fukui
DISEASES (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
the prevention of hepatitis B-related hepatocellular carcinoma
C. -L. Lin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
Giovanni Musso et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Xiaobo Cai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice
Jingxiao Wang et al.
ONCOGENE (2018)
Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
Naofumi Mukaida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
Anqiang Wang et al.
NATURE COMMUNICATIONS (2018)
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma
Michele Simbolo et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Necroptosis microenvironment directs lineage commitment in liver cancer
Marco Seehawer et al.
NATURE (2018)
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Marcus Grohmann et al.
CELL (2018)
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies
Debora Maria Giordano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy
Hu Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
Joanne Marie O'Rourke et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
Marta Garnelo et al.
GUT (2017)
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Sofia M. E. Weiler et al.
GASTROENTEROLOGY (2017)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
Agrin Moeini et al.
JOURNAL OF HEPATOLOGY (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shabnam Shalapour et al.
NATURE (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy
Han-Yue Mo et al.
PLOS ONE (2017)
Immunotherapeutic approaches for hepatocellular carcinoma
Vito Longo et al.
ONCOTARGET (2017)
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (vol 18, pg 2780, 2017)
Farshad Farshidfar et al.
CELL REPORTS (2017)
Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC
Akira Asai et al.
ONCOIMMUNOLOGY (2017)
Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
Nobuhiro Tsuchiya et al.
ONCOIMMUNOLOGY (2017)
Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?
Eugene J. Koay et al.
HEPATOBILIARY SURGERY AND NUTRITION (2017)
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
Yannick Boege et al.
CANCER CELL (2017)
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS
Detian Yuan et al.
CANCER CELL (2017)
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
James J. Harding et al.
CANCER (2016)
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver
Monika Rau et al.
JOURNAL OF IMMUNOLOGY (2016)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
The Liver at the Nexus of Host-Microbial Interactions
Andrew J. Macpherson et al.
CELL HOST & MICROBE (2016)
Immunological functions of liver sinusoidal endothelial cells
Percy A. Knolle et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Liver immunology and its role in inflammation and homeostasis
Mark W. Robinson et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
The role of innate immunity in the immunopathology and treatment of HBV infection
Mala K. Maini et al.
JOURNAL OF HEPATOLOGY (2016)
IL-6 pathway in the liver: From physiopathology to therapy
Dirk Schmidt-Arras et al.
JOURNAL OF HEPATOLOGY (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Immunology in the liver - from homeostasis to disease
Felix Heymann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
ROS and ROS-Mediated Cellular Signaling
Jixiang Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma
Hao Wu et al.
TUMOR BIOLOGY (2016)
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed
An-Qiang Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Challenges of advanced hepatocellular carcinoma
Stefano Colagrande et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics
John R. Bergquist et al.
HPB (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma
Maiko Terada et al.
SCIENTIFIC REPORTS (2016)
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Differential Effects of Targeting Notch Receptors in a Mouse Model of Liver Cancer
Erik G. Huntzicker et al.
HEPATOLOGY (2015)
Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity
Sanda Win et al.
JOURNAL OF HEPATOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease
Pia Manninen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis
Hongtan Wu et al.
NATURE COMMUNICATIONS (2015)
Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma
Jinghan Wang et al.
ONCOTARGET (2015)
Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
Ching-Sheng Hsu et al.
SCIENTIFIC REPORTS (2015)
Intratumor Heterogeneity in Hepatocellular Carcinoma
Juliane Friemel et al.
CLINICAL CANCER RESEARCH (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?
Akinobu Takaki et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Risk Prediction of Hepatocellular Carcinoma in Patients With Cirrhosis: The ADRESS-HCC Risk Model
Jennifer A. Flemming et al.
CANCER (2014)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
Krishna S. Tummala et al.
CANCER CELL (2014)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Darjus F. Tschaharganeh et al.
CELL (2014)
Microbiota-Liver Axis in Hepatic Disease
Benoit Chassaing et al.
HEPATOLOGY (2014)
Immune Tolerance in Liver Disease
Ian N. Crispe
HEPATOLOGY (2014)
The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans
Luis Chavez-Sanchez et al.
HUMAN IMMUNOLOGY (2014)
Analysis of the genomic profile of biphenotypic tumors compared to cholangiocarcinoma and hepatocellular carcinoma
Jesse W. Keller et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer
Atsushi Aruga et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Supriya K. Saha et al.
NATURE (2014)
Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway
Romilda Cardin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Mitesh J. Borad et al.
PLOS GENETICS (2014)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
Darjus Felix Tschaharganeh et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome
Scott Robertson et al.
HUMAN PATHOLOGY (2013)
Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test
Yusuke Suzuki et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
Shingo Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer
Masanori Kobayashi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies
Rebecca M. Dodson et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+T cells and successful immunotherapy against chronic viral liver infection
Li-Rung Huang et al.
NATURE IMMUNOLOGY (2013)
Aflatoxins, hepatocellular carcinoma and public health
Arvin Magnussen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
KrasG12D and p53 Mutation Cause Primary intrahepatic Cholangiocarcinoma
Michael R. O'Dell et al.
CANCER RESEARCH (2012)
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
Koichi Shimizu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung et al.
NATURE GENETICS (2012)
Inflammation- and stress-related signaling pathways in hepatocarcinogenesis
Hayato Nakagawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Living in the liver: hepatic infections
Ulrike Protzer et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Crosstalk of reactive oxygen species and NF-kappa B signaling
Michael J. Morgan et al.
CELL RESEARCH (2011)
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2011)
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet
Nicolas Lanthier et al.
FASEB JOURNAL (2011)
Oxidative Stress Pathways in Noncancerous Human Liver Tissue to Predict Hepatocellular Carcinoma Recurrence: A Prospective, Multicenter Study
Shinji Tanaka et al.
HEPATOLOGY (2011)
Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
Miho Kaida et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Chronic Liver Diseases as Liver Tumor Precursors
Jan Lata
DIGESTIVE DISEASES (2010)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154
Mareike Mueller et al.
JOURNAL OF HEPATOLOGY (2010)
As Based upon Physiological and Pathological Histology
RUDOLF VIRCHOW
NUTRITION REVIEWS (2010)
Toll-like Receptor 4 and Hepatic Fibrogenesis
Jean-Philippe Pradere et al.
SEMINARS IN LIVER DISEASE (2010)
The Liver as a Lymphoid Organ
Ian Nicholas Crispe
ANNUAL REVIEW OF IMMUNOLOGY (2009)
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Johannes Haybaeck et al.
CANCER CELL (2009)
Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature
Murad Aljiffry et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma
Akira Maki et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression
Hania Wehbe et al.
CANCER RESEARCH (2006)
Toll-like receptor signaling in the liver
Robert F. Schwabe et al.
GASTROENTEROLOGY (2006)
Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma
S Yamada et al.
EJSO (2006)
Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo
SS Zhan et al.
HEPATOLOGY (2006)
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression
Y Ikura et al.
HEPATOLOGY (2006)
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholanglocarcinoma cells
H Isomoto et al.
HEPATOLOGY (2005)
Hepatitis C virus induces a mutator phenotype: Enhanced mutations of immunoglobulin and protooncogenes
K Machida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
YH Shaib et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
A Canbay et al.
HEPATOLOGY (2003)
Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes
M Jaiswal et al.
GASTROENTEROLOGY (2001)
分享论文
